NPR News: Cancer Drugs Approved Quickly Often Fail To Measure Up Later

Cancer Drugs Approved Quickly Often Fail To Measure Up Later
Regulators give many cancer drugs a fast track to market while requiring drugmakers to do more studies after approval. Researchers have found the follow-up studies frequently come up short.

Read more on NPR
May 29, 2019 at 12:56AM
Health Care